CU20160119A7 - Formulaciones tópicas de heparina - Google Patents

Formulaciones tópicas de heparina

Info

Publication number
CU20160119A7
CU20160119A7 CUP2016000119A CU20160119A CU20160119A7 CU 20160119 A7 CU20160119 A7 CU 20160119A7 CU P2016000119 A CUP2016000119 A CU P2016000119A CU 20160119 A CU20160119 A CU 20160119A CU 20160119 A7 CU20160119 A7 CU 20160119A7
Authority
CU
Cuba
Prior art keywords
topical formulations
present
heparine
formulations
topical
Prior art date
Application number
CUP2016000119A
Other languages
English (en)
Other versions
CU24444B1 (es
Inventor
K R Patel
M R Patel
A K Patel
Prakash J Shah
Original Assignee
Troikaa Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52684592&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CU20160119(A7) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Troikaa Pharmaceuticals Ltd filed Critical Troikaa Pharmaceuticals Ltd
Publication of CU20160119A7 publication Critical patent/CU20160119A7/es
Publication of CU24444B1 publication Critical patent/CU24444B1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se relaciona con formulaciones tópicas avanzadas de sales farmacéuticamente aceptables de Heparina que proporcionan penetración transdérmica mejorada. La presente invención proporciona formulaciones líquidas, no pegajosas, claras en las que el fármaco está listo para la absorción y que son adecuadas para administración en la forma de una solución o una pulverización. Las formulaciones tópicas de la presente invención no forman película con escamas o similar al gel sobre la superficie de la piel luego de aplicación tópica.
CU2016000119A 2014-02-10 2015-02-10 Formulaciones tópicas de heparina CU24444B1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN475MU2014 2014-02-10
PCT/IB2015/050986 WO2015118512A1 (en) 2014-02-10 2015-02-10 Topical formulations of heparin

Publications (2)

Publication Number Publication Date
CU20160119A7 true CU20160119A7 (es) 2016-10-28
CU24444B1 CU24444B1 (es) 2019-10-04

Family

ID=52684592

Family Applications (1)

Application Number Title Priority Date Filing Date
CU2016000119A CU24444B1 (es) 2014-02-10 2015-02-10 Formulaciones tópicas de heparina

Country Status (25)

Country Link
US (1) US9861655B2 (es)
EP (1) EP3104839B1 (es)
JP (1) JP6275877B2 (es)
KR (1) KR101822133B1 (es)
CN (1) CN106163498A (es)
AP (1) AP2016009350A0 (es)
AR (1) AR099333A1 (es)
AU (1) AU2015213569B2 (es)
CA (1) CA2938388C (es)
CL (1) CL2016001952A1 (es)
CU (1) CU24444B1 (es)
DK (1) DK3104839T3 (es)
DO (1) DOP2016000198A (es)
EA (1) EA032200B1 (es)
EC (1) ECSP16069947A (es)
IL (1) IL246974B (es)
MA (1) MA39304B1 (es)
MX (1) MX357765B (es)
MY (1) MY182620A (es)
NZ (1) NZ722830A (es)
PE (1) PE20161173A1 (es)
PH (1) PH12016501500B1 (es)
TW (1) TWI538697B (es)
UA (1) UA118279C2 (es)
WO (1) WO2015118512A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011130455A1 (en) * 2010-04-13 2011-10-20 Najib Babul Dermal pharmaceutical compositions of 1-methyl-2',6'-pipecoloxylidide and method of use
CN112546061B (zh) * 2021-02-25 2021-06-11 中南大学湘雅医院 一种肝素类药物组合物、喷鼻剂及其制备方法及应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3323389A1 (de) * 1983-06-29 1985-01-10 B. Braun Melsungen Ag, 3508 Melsungen Auf schleimhaeute des mundes, der nase und/oder des rachens wirkende arzneimittel auf der basis von heparin und tensiden
JPH02207018A (ja) * 1989-02-07 1990-08-16 Kao Corp 皮膚外用剤
ATE223202T1 (de) 1994-09-30 2002-09-15 Mika Pharma Ges Fuer Die Entwi Pharmazeutische zusammensetzung
IT1275955B1 (it) 1995-03-22 1997-10-24 Dompe Spa Formulazioni farmaceutiche in forma di gel tissotropico
JPH10279466A (ja) * 1997-04-07 1998-10-20 Kose Corp 外用剤
US6761903B2 (en) * 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
BRPI0101486B1 (pt) 2001-04-17 2017-09-19 Cristália Produtos Químicos Farmacêuticos Ltda. Pharmaceutical composition for topic use containing heparin for the treatment of skin or mucosal injuries caused by burns
RU2467759C2 (ru) * 2006-11-15 2012-11-27 Артрайтис Рилиф Плас Лтд Состав для местного использования и его применения
IT1400232B1 (it) * 2010-05-07 2013-05-24 Advance Holdings Ltd Composizione farmaceutica topica comprendente eparina
WO2012135422A2 (en) * 2011-04-01 2012-10-04 University Of Florida Research Foundation, Inc. Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics

Also Published As

Publication number Publication date
MX2016010399A (es) 2017-02-23
EP3104839B1 (en) 2019-11-13
NZ722830A (en) 2018-01-26
KR20160117529A (ko) 2016-10-10
PH12016501500A1 (en) 2017-02-06
CA2938388C (en) 2018-07-17
CU24444B1 (es) 2019-10-04
US20170165291A1 (en) 2017-06-15
JP6275877B2 (ja) 2018-02-07
DK3104839T3 (da) 2020-01-20
PH12016501500B1 (en) 2017-02-06
PE20161173A1 (es) 2016-10-27
CL2016001952A1 (es) 2017-03-10
UA118279C2 (uk) 2018-12-26
ECSP16069947A (es) 2018-06-30
CN106163498A (zh) 2016-11-23
MA39304B1 (fr) 2018-12-31
TWI538697B (zh) 2016-06-21
AU2015213569B2 (en) 2018-01-04
EA201691596A1 (ru) 2017-01-30
AP2016009350A0 (en) 2016-07-31
KR101822133B1 (ko) 2018-01-25
IL246974B (en) 2018-07-31
AU2015213569A1 (en) 2016-08-18
DOP2016000198A (es) 2016-10-31
US9861655B2 (en) 2018-01-09
MX357765B (es) 2018-07-23
CA2938388A1 (en) 2015-08-13
MY182620A (en) 2021-01-27
EP3104839A1 (en) 2016-12-21
MA39304A1 (fr) 2018-01-31
EA032200B1 (ru) 2019-04-30
TW201532631A (zh) 2015-09-01
WO2015118512A1 (en) 2015-08-13
AR099333A1 (es) 2016-07-13
JP2017505344A (ja) 2017-02-16

Similar Documents

Publication Publication Date Title
DK3273942T3 (da) Mikronåleplaster til indgivelse af en aktiv bestanddel til huden
BR112016028961A2 (pt) composições compreendendo fibras obtidas por via eletro-hidrodinâmica para administração de dosagens específicas de uma substância ativa à pele ou mucosa
MX2018001723A (es) Conjugados farmaco-multiligando y usos de los mismos.
DOP2015000246A (es) Derivados de oxopiridina sustituida y usos de los mismos en el tratamiento de trastornos cardiovasculares
CL2015002733A1 (es) Composición farmacéutica de clorhidrato de s-cetamina.
MX384073B (es) Una composicion farmaceutica para reducir la grasa localizada y sus usos.
BR112017007123A2 (pt) derivados de tetrahidroisoquinolina
BR112016000350A8 (pt) métodos de tratamento de lesões inflamatórias da rosácea e usos de uma composição farmacêutica
AR096402A1 (es) Medicamento de metformina y dihidroquercetina
CR20150360A (es) Sistema de liberación transdérmica
CY1124294T1 (el) Τοπικο σκευασμα
MX2016013236A (es) Formulacion inmunosupresora.
DOP2016000297A (es) Composiciones farmacéuticas útiles para tratar enfermedades infecciosas
ECSP16086247A (es) (s)-pirlindole y sus sales farmacéuticamente aceptables para uso en medicina
PE20150721A1 (es) Composicion farmaceutica que comprende gemigliptina y metformina, y metodo para su preparacion
CU20160119A7 (es) Formulaciones tópicas de heparina
CL2016000397A1 (es) Tratamiento contra el cáncer
MX2016014701A (es) (r)-pirlindol y sus sales farmaceuticamente aceptables para uso en medicina.
MX2019009909A (es) Composiciones farmaceuticas para terapia de combinacion.
CL2016000543A1 (es) Uso de pidotimod o sus estereoisómeros y/o sales fisiológicamente aceptables para preparar un medicamento útil en el tratamiento de enfermedades asociadas con la inflamación, donde hay una hiperactivación aberrante de la vía no canónica de nfkb.
EA201501130A1 (ru) Офтальмологическая фармацевтическая композиция
MX2018004984A (es) Formulaciones de isotretinoina y usos y metodos de las mismas.
AR098771A1 (es) Un dispositivo para la administración transdérmica de rotigotina
CR20140526A (es) Dronedarona para uso en la leishmaniosis, formulaciones y asociaciones para uso en la leishmaniosis
AR130700A2 (es) Composiciones de grapiprant y métodos para su utilización